Versor Investments LP Buys 37,400 Shares of Option Care Health, Inc. $OPCH

Key Points

• Versor Investments LP increased its holdings in Option Care Health, Inc. by 191.8%, acquiring an additional 37,400 shares to reach a total of 56,900 shares worth approximately $1.99 million.
• Several institutional investors have also boosted their stakes in Option Care Health, with overall institutional ownership at 98.05%.
• Option Care Health reported a quarterly EPS of $0.41, exceeding analyst expectations, and recorded a 15.4% year-over-year revenue increase, totaling $1.42 billion.

Versor Investments LP increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 191.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 56,900 shares of the company's stock after acquiring an additional 37,400 shares during the quarter. Versor Investments LP's holdings in Option Care Health were worth $1,989,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of OPCH. Wells Fargo & Company MN lifted its stake in shares of Option Care Health by 9.5% in the fourth quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock worth $4,185,000 after acquiring an additional 15,609 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Option Care Health by 2,032.6% in the fourth quarter. Renaissance Technologies LLC now owns 330,546 shares of the company's stock worth $7,669,000 after acquiring an additional 315,046 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Option Care Health in the fourth quarter worth about $2,027,000. Sterling Capital Management LLC lifted its stake in shares of Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after acquiring an additional 2,554 shares in the last quarter. Finally, Barclays PLC increased its holdings in Option Care Health by 37.5% in the fourth quarter. Barclays PLC now owns 426,532 shares of the company's stock valued at $9,895,000 after buying an additional 116,338 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Stock Up 2.9%

Shares of NASDAQ OPCH traded up $0.82 during mid-day trading on Friday, reaching $28.66. The company had a trading volume of 1,158,644 shares, compared to its average volume of 1,853,409. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a market capitalization of $4.65 billion, a PE ratio of 22.94, a price-to-earnings-growth ratio of 1.72 and a beta of 0.79. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock's 50 day moving average is $29.98 and its 200-day moving average is $31.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The shares were bought at an average cost of $27.15 per share, with a total value of $977,400.00. Following the completion of the transaction, the director owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction dated Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the transaction, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company's stock.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research analyst reports. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.